Nippon India Nifty Pharma ETF
ETFs FundNAV
21.22(-0.16%)Fund Size (CR)
₹866.14Expense Ratio
0.21Scheme Type
Passive FundValue Research
Min. investment
₹1,000Minimum Additional Investment
₹0Minimum SIP Investment
₹undefinedMinimum Withdrawal
₹0Exit Load
0%Return Since Launch
11.32%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Jitendra Tolani
Bench Mark
Nifty Pharma TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 12 February 2025 | 9850.16 | -1.50% | - | -0.22% | 193/236 |
| 1 Month | 17 January 2025 | 9456.41 | -5.44% | - | -1.22% | 181/234 |
| 3 Month | 19 November 2024 | 9580.80 | -4.19% | - | -1.65% | 150/232 |
| 6 Month | 19 August 2024 | 9372.78 | -6.27% | - | -2.68% | 114/219 |
| 1 Year | 19 February 2024 | 10977.89 | 9.78% | 9.78% | 10.13% | 42/199 |
| 3 Year | 18 February 2022 | 16012.10 | 60.12% | 16.99% | 13.51% | 34/126 |
| 5 Year | - | - | 0% | - | 14.98% | -/- |
| Since Inception | 6 July 2021 | 14753.78 | 47.54% | 11.32% | 14.47% | 139/236 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 1 March 2024 | 1,20,000 | 119168.18 | -0.69% | -0.69% |
| 3 Year | 2 March 2022 | 3,60,000 | 492278.28 | 36.74% | 10.99% |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.71%
Standard Deviation
1.00%
Beta
0.67%
Sharpe Ratio
0.13%
Treynor's Ratio
-0.23%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 24.97% | 1240110 | 216.27 | Equity | Pharmaceuticals |
| Cipla | 10.78% | 631406 | 93.41 | Equity | Pharmaceuticals |
| Dr Reddy's Labs | 9.85% | 700715 | 85.30 | Equity | Pharmaceuticals |
| Divi's Lab. | 9.40% | 145942 | 81.40 | Equity | Pharmaceuticals |
| Lupin | 6.65% | 276849 | 57.60 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 4.34% | 321056 | 37.62 | Equity | Pharmaceuticals |
| Torrent Pharma. | 4.07% | 107803 | 35.24 | Equity | Pharmaceuticals |
| Alkem Lab | 3.57% | 61044 | 30.91 | Equity | Pharmaceuticals |
| Mankind Pharma | 3.35% | 119311 | 29.06 | Equity | Pharmaceuticals |
| Zydus Lifesci. | 3.22% | 287059 | 27.85 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|
News
Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)
Nippon India Mutual Fund has announced 14 February 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the regular plan ' IDCW payout and direct plan ' IDCW payout of Nippon India Balanced Advantage Fund. The quantum of distribution will be Rs 0.2000 per unit under each plan / option as on the record date.Powered by Capital Market - Live News
Nippon India launches Active Momentum Fund
Nippon India Mutual Fund has announced the launch of the Nippon India Active Momentum Fund, an open-ended equity scheme focused on long-term capital appreciation. The fund will invest in a diversified portfolio of equity and equity-related instruments, utilizing a momentum-based strategy to identify and invest in high-performing stocks.The NFO is currently open for subscription and will close on February 24th, reopening for continuous sale and repurchase on March 6th. The minimum investment during the NFO is Rs 500, with subsequent investments allowed in multiples of Re 1. The fund's benchmark is the Nifty 500 TRI. Ashutosh Bhargava and Kinjal Desai will serve as the fund managers.
The fund offers both direct and regular plans, each with growth and income distribution cum capital withdrawal options. A 1% exit load applies if units are redeemed or switched out within one year of allotment; after one year, there is no exit load.
The Nippon India Active Momentum Fund employs a multi-factor quantitative model designed to identify high-potential investment opportunities while managing volatility and adapting to market cycles. This model integrates price momentum with earnings revisions, combining technical and fundamental analysis to optimize returns. This approach aims to capitalize on market trends while incorporating insights into earnings growth.
The fund also utilizes a Risk ON and Risk OFF framework. In Risk ON phases, the fund incorporates the Beta factor alongside momentum to enhance upside potential. During Risk OFF phases, it prioritizes minimum volatility to mitigate risk and stabilize performance. The portfolio is rebalanced monthly to dynamically adapt to market changes.
Further, the fund may incorporate factors like Minimum Volatility and Beta to potentially reduce risk during market downturns and enhance returns during uptrends, offering investors access to momentum strategies with potentially reduced volatility. The fund strategy aims to blend market trends (price momentum) with expert insights (earnings revisions), effectively combining technical and fundamental factors.
Powered by Capital Market - Live News
Nippon India MF announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes
Nippon India Mutual Fund has announced 06 February 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Nippon India Small Cap Fund:
Regular Plan ' IDCW: 7.50
Direct Plan ' IDCW: 8.00
Nippon India Banking & Financial Services Fund:
Regular Plan ' IDCW: 5.50
Direct Plan ' IDCW: 7.00
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
21 June 2021
Total AUM (Cr)
₹866.14
Nippon India Nifty Pharma ETF is an ETFs Fund-oriented fund from the renowned AMC, Nippon India Mutual Fund. Launched in 21 June 2021, this fund is managed by Jitendra Tolani. With assets under management (AUM) worth ₹866.14 (Cr), as of 20 February 2025, Nippon India Nifty Pharma ETF is categorized as a ETFs Fund within its segment. The fund has generated a return of 11.32% since its launch.
The current NAV of Nippon India Nifty Pharma ETF is ₹21.22, as on 20 February 2025. The fund's benchmark index is Nifty Pharma TRI. You can invest in Nippon India Nifty Pharma ETF via both lumpsum and SIP modes. The minimum SIP amount in the fund is - while the minimum lumpsum investment is ₹1,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
Nil The fund has generated 16.99% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 99.94% in Equity, 0.04% in Debt and 0.02% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 99.94% in Pharmaceuticals & Biotech, 0.04% in Debt, 0.02% in Cash & Others
FAQs
How to Invest in Nippon India Nifty Pharma ETF Direct Growth?
Nippon India Nifty Pharma ETF is a popular fund in the ETFs Fund segment. The fund has generated a return of 11.32% since inception. Looking to invest in Nippon India Nifty Pharma ETF How about earning 1% extra return? All this is possible with m.Stock! Investing in Nippon India Nifty Pharma ETF is super easy and convenient with m.Stock. Here’s how you can begin:
- Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage across products for life.
- In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
- In the search bar, enter the fund name, in this case, Nippon India Nifty Pharma ETF
- On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
- If you choose to invest a Lumpsum: Enter amount, select payment mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
- If you choose the SIP route, then enter SIP amount, SIP date, and set up ‘Autopay’ facility.
So, why wait? Invest in Nippon India Nifty Pharma ETF today and reap the benefits of this ETFs Fund fund!
How much returns has Nippon India Nifty Pharma ETF Direct Growth generated?
What is the expense ratio of Nippon India Nifty Pharma ETF Direct Growth?
What is the AUM of Nippon India Nifty Pharma ETF Fund Direct Growth?
How to redeem or withdraw money from Nippon India Nifty Pharma ETF Direct Growth?
Redeeming or selling units of Nippon India Nifty Pharma ETF is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.
To redeem from Nippon India Nifty Pharma ETF:
- Login to your m.Stock account
- In portfolio, your mutual fund investments will be visible under ‘MF’
- Select the fund you wish to redeem from (in this case Nippon India Nifty Pharma ETF).
- Click on ‘Redeem’ button
- You have 2 options – redeem by units and redeem by value (you can only redeem free units)
- Select units to be redeemed and click on submit.
- Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).